IMMUNOCHEMICAL DETECTION OF ACETAMINOPHEN-BOUND LIVER PROTEINS

被引：106

作者：

BARTOLONE, JB

SPARKS, K

COHEN, SD

KHAIRALLAH, EA

机构：

[1] UNIV CONNECTICUT,DEPT MOLEC & CELL BIOL,STORRS,CT 06268

[2] UNIV CONNECTICUT,DEPT PHARMACOL & TOXICOL,STORRS,CT 06268

来源：

BIOCHEMICAL PHARMACOLOGY | 1987年 / 36卷 / 08期

关键词：

D O I：

10.1016/0006-2952(87)90069-4

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：1193 / 1196

页数：4

共 11 条

[1]

COLEMAN JW, 1986, J IMMUNOL METHODS, V88, P37, DOI 10.1016/0022-1759(86)90049-9

[2] PERSPECTIVE ON ROLE OF CHEMICALLY REACTIVE METABOLITES OF FOREIGN COMPOUNDS IN TOXICITY .1. CORRELATION OF CHANGES IN COVALENT BINDING OF REACTIVITY METABOLITES WITH CHANGES IN INCIDENCE AND SEVERITY OF TOXICITY [J].

GILLETTE, JR .

BIOCHEMICAL PHARMACOLOGY, 1974, 23 (20) :2785-2794

[3] PERSPECTIVE ON ROLE OF CHEMICALLY REACTIVE METABOLITES OF FOREIGN COMPOUNDS IN TOXICITY .2. ALTERATIONS IN KINETICS OF COVALENT BINDING [J].

GILLETTE, JR .

BIOCHEMICAL PHARMACOLOGY, 1974, 23 (21) :2927-2938

[4] PROTECTION AGAINST ACETAMINOPHEN-INDUCED HEPATOTOXICITY BY PRIOR TREATMENT WITH FENITROTHION [J].

GINSBERG, GL ;

PLACKE, ME ;

WYAND, DS ;

COHEN, SD .

TOXICOLOGY AND APPLIED PHARMACOLOGY, 1982, 66 (03) :383-399

[5]

HINSON JA, 1980, REV BIOCH TOXICOLOGY, V2, P131

[6]

JOLLOW DJ, 1973, J PHARMACOL EXP THER, V187, P195

[7]

MITCHELL JR, 1973, J PHARMACOL EXP THER, V187, P211

[8]

SARRIF AM, 1976, BIOCH BIOPHYS RES CO, V70, P3

[9] THE COVALENT BINDING OF ACETAMINOPHEN TO PROTEIN - EVIDENCE FOR CYSTEINE RESIDUES AS MAJOR SITES OF ARYLATION INVITRO [J].

STREETER, AJ ;

DAHLIN, DC ;

NELSON, SD ;

BAILLIE, TA .

CHEMICO-BIOLOGICAL INTERACTIONS, 1984, 48 (03) :349-366

[10] MACROMOLECULAR WEIGHT SPECIFICITY IN COVALENT BINDING OF BROMOBENZENE [J].

SUN, JD ;

DENT, JG .

TOXICOLOGY AND APPLIED PHARMACOLOGY, 1984, 76 (02) :243-251

← 1 2 →